| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.5 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.5 |